Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro
and in vivo
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 175, Issue 5, Pages 810-829
Publisher
Wiley
Online
2017-12-13
DOI
10.1111/bph.14126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preliminary Exploration on Anti-Fibrosis Effect of Kaempferol in Mice with Schistosoma Japonicum Infection
- (2017) Y-P. Zhou et al. European Journal of Inflammation
- Activity of Corilagin on Post-Parasiticide Liver Fibrosis in Schistosomiasis Animal Model
- (2017) Y.-F. Huang et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Mechanism of Corilagin interference with IL-13/STAT6 signaling pathways in hepatic alternative activation macrophages in schistosomiasis-induced liver fibrosis in mouse model
- (2016) Peng Du et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease
- (2016) Frank J. Gonzalez et al. GASTROENTEROLOGY
- Preliminary study on Emodin alleviating alpha-naphthylisothiocyanate-induced intrahepatic cholestasis by regulation of liver farnesoid X receptor pathway
- (2016) Yan Ding et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Corilagin ameliorates schistosomiasis hepatic fibrosis through regulating IL-13 associated signal pathway in vitro and in vivo
- (2016) HUA-RONG LI et al. PARASITOLOGY
- Effect of Corilagin on the miR-21/smad7/ERK signaling pathway in a schistosomiasis-induced hepatic fibrosis mouse model
- (2016) Fan Yang et al. PARASITOLOGY INTERNATIONAL
- Serum Metabolomic Profiling in a Rat Model Reveals Protective Function of Paeoniflorin Against ANIT Induced Cholestasis
- (2016) Zhe Chen et al. PHYTOTHERAPY RESEARCH
- Profiles of responses of immunological factors to different subtypes of Kawasaki disease
- (2015) Yan Ding et al. BMC MUSCULOSKELETAL DISORDERS
- Experimental design and analysis and their reporting: new guidance for publication in BJP
- (2015) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP
- (2015) John C McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pathological features of transplanted tumor established by CD133 positive TJ905 glioblastoma stem-like cells
- (2015) Feng Jin et al. Cancer Cell International
- Therapy of Primary Biliary Cirrhosis: Novel Approaches for Patients with Suboptimal Response to Ursodeoxycholic Acid
- (2015) Albert Parés DIGESTIVE DISEASES
- Farnesoid X receptor modulators (2011 – 2014): a patent review
- (2015) Valentina Sepe et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond
- (2015) Ulrich Beuers et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
- (2015) Christopher Southan et al. NUCLEIC ACIDS RESEARCH
- Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders
- (2015) Stefano Fiorucci et al. TRENDS IN MOLECULAR MEDICINE
- Bile acid nuclear receptor FXR and digestive system diseases
- (2015) Lili Ding et al. Acta Pharmaceutica Sinica B
- Nuclear bile acid signaling through the farnesoid X receptor
- (2014) Claire Mazuy et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Corilagin Protects Against HSV1 Encephalitis Through Inhibiting the TLR2 Signaling Pathways In Vivo and In Vitro
- (2014) Yuan-Jin Guo et al. MOLECULAR NEUROBIOLOGY
- Effects of Bile Acids and the Bile Acid Receptor FXR Agonist on the Respiratory Rhythm in the In Vitro Brainstem Medulla Slice of Neonatal Sprague-Dawley Rats
- (2014) Cong Zhao et al. PLoS One
- A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways
- (2013) Luoqi Jia et al. BMC Complementary and Alternative Medicine
- Anti-inflammatory and anti-oxidative effects of corilagin in a rat model of acute cholestasis
- (2013) Feng Jin et al. BMC GASTROENTEROLOGY
- Anti-Helicobacter pylori compounds from the ethanol extracts of Geranium wilfordii
- (2013) Xi-Quan Zhang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells
- (2012) Roberto Gambari et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- S-adenosylmethionine in Liver Health, Injury, and Cancer
- (2012) Shelly C. Lu et al. PHYSIOLOGICAL REVIEWS
- Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome
- (2011) Christophe Corpechot et al. JOURNAL OF HEPATOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of Corilagin on anti-inflammation in HSV-1 encephalitis and HSV-1 infected microglias
- (2010) Yuan-Jin Guo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Primary hepatocyte culture supports hepatitis C virus replication: A model for infection-associated hepatocarcinogenesis
- (2010) Krishna Banaudha et al. HEPATOLOGY
- Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis
- (2010) Sayeepriyadarshini Anakk et al. JOURNAL OF CLINICAL INVESTIGATION
- Nuclear receptors as therapeutic targets in cholestatic liver diseases
- (2009) Gernot Zollner et al. BRITISH JOURNAL OF PHARMACOLOGY
- TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
- (2009) Charles Thomas et al. Cell Metabolism
- Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid
- (2009) Edith M.M. Kuiper et al. GASTROENTEROLOGY
- New molecular insights into the mechanisms of cholestasis
- (2009) Martin Wagner et al. JOURNAL OF HEPATOLOGY
- Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway
- (2008) Yan Ding et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
- (2008) Christophe Corpechot et al. HEPATOLOGY
- Preliminary exploration on anti-inflammatory mechanism of Corilagin (beta-1-O-galloyl-3,6-(R)-hexahydroxydiphenoyl-d-glucose) in vitro
- (2008) Lei Zhao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started